Stock Research for AERI

AERI
Current Price

$60.1500


Latest Update: 2017-12-14 16:00:00

High
$ 60.2500
Low
$ 60.1000
Close
$ 60.1500
Volume
14933
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AERI Stock Chart & Research Data

The AERI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AERI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AERI Due diligence Resources & Stock Charts

The AERI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AERI Detailed Price Forecast - CNN Money CNN View AERI Detailed Summary - Google Finance
Yahoo View AERI Detailed Summary - Yahoo! Finance Zacks View AERI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AERI Trends & Analysis - Trade-Ideas Barrons View AERI Major Holders - Barrons
NASDAQ View AERI Call Transcripts - NASDAQ Seeking View AERI Breaking News & Analysis - Seeking Alpha
Spotlight View AERI Annual Report - CompanySpotlight.com OTC Report View AERI OTC Short Report - OTCShortReport.com
TradeKing View AERI Fundamentals - TradeKing Charts View AERI SEC Filings - Bar Chart
WSJ View Historical Prices for AERI - The WSJ Morningstar View Performance/Total Return for AERI - Morningstar
MarketWatch View the Analyst Estimates for AERI - MarketWatch CNBC View the Earnings History for AERI - CNBC
StockMarketWatch View the AERI Earnings - StockMarketWatch MacroAxis View AERI Buy or Sell Recommendations - MacroAxis
Bullish View the AERI Bullish Patterns - American Bulls Short Pains View AERI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AERI Stock Mentions - StockTwits PennyStocks View AERI Stock Mentions - PennyStockTweets
Twitter View AERI Stock Mentions - Twitter Invest Hub View AERI Investment Forum News - Investor Hub
Yahoo View AERI Stock Mentions - Yahoo! Message Board Seeking Alpha View AERI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AERI - SECform4.com Insider Cow View Insider Transactions for AERI - Insider Cow
CNBC View AERI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AERI - OTC Markets
Yahoo View Insider Transactions for AERI - Yahoo! Finance NASDAQ View Institutional Holdings for AERI - NASDAQ


Stock Charts

FinViz View AERI Stock Insight & Charts - FinViz.com StockCharts View AERI Investment Charts - StockCharts.com
BarChart View AERI Stock Overview & Charts - BarChart Trading View View AERI User Generated Charts - Trading View


Latest Financial News for AERI

Why Is Aerie (AERI) Down 5.9% Since the Last Earnings Report?
Posted on Monday December 11, 2017

Aerie (AERI) reported earnings more than 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Aerie Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
Posted on Monday December 11, 2017

Aerie Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 85.


Falling Earnings Estimates Signal Weakness Ahead for Aerie Pharmaceuticals (AERI)
Posted on Thursday December 07, 2017

Aerie Pharmaceuticals (AERI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.


Aerie Pharmaceuticals Announces Appointment of Heather Johnson as Regional Sales Director for the Northeast Region
Posted on Monday December 04, 2017

Aerie Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Heather Johnson as Regional Sales Director for the Northeast Region, reporting to Gary Menichini, Aerie’s Vice President of Sales.


After Today's Big Increase, Is Aerie Pharmaceuticals, Inc. (AERI)'s Near-Term ...
Finance News Daily - 7 hours ago
California Employees Retirement System has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Pennsylvania-based Sei Company has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Dekabank Deutsche Girozentrale invested in 15,900 shares ...
Analysts Expect Aerie Pharmaceuticals, Inc. (AERI) Will Post Earnings of -$0 ... - The Ledger Gazette
Aerie Pharmaceuticals establishes state of the art manufacturing facility in ... - Galway Advertiser

Zacks: Brokerages Anticipate Aerie Pharmaceuticals, Inc. (AERI) to Post -$1.44 ...
Week Herald - Aug 3, 2017
Aerie Pharmaceuticals logo Wall Street brokerages expect Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report earnings of ($1.44) per share for the current fiscal quarter, Zacks reports.

This Might Be The Best Time To Pick Up Aerie Pharmaceuticals In 2017
Seeking Alpha - Oct 23, 2017
... pharmaceutical company to becoming a full-fledged commercial organization. And with the probability of securing FDA approval for its investigational glaucoma drug, Rhopressa in early 2018, increasing after positive recommendation from FDA's ...
Aerie Pharmaceuticals, Inc. (AERI) Now Covered by Guggenheim - The Ledger Gazette
UPDATE: Guggenheim Starts Aerie Pharma (AERI) at Buy - StreetInsider.com

Aerie Pharmaceuticals Inc. (AERI) Has Jumped To A New High On FDA News
Nasdaq - Oct 11, 2017
Aerie Pharmaceuticals Inc. (AERI) Has Jumped To A New High On FDA News. October 11, 2017, 09:36:00 AM EDT By RTT News. loading.
Aerie Pharma's FDA Briefing Docs: Good News With No Surprises; Shares Scale A ... - Benzinga
Aerie Pharmaceuticals Inc's (AERI) Glaucoma Drug Is Poised for a Favorable ... - Smarter Analyst

Enter a stock symbol to view the stock details.